Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials

MLA

Ruth Sim, et al. “Comparative Effectiveness of Cardiovascular, Renal and Safety Outcomes of Second‐line Antidiabetic Drugs Use in People with Type 2 Diabetes: A Systematic Review and Network Meta‐analysis of Randomised Controlled Trials.” Diabetic Medicine, vol. 39, Jan. 2022. EBSCOhost, https://doi.org/10.1111/dme.14780.

APA

Ruth Sim, Chun Wie Chong, Navin K. Loganadan, Alan Y. Y. Fong, Leenhapong Navaravong, Zanariah Hussein, Kamlesh Khunti, & Shaun Wen Huey Lee. (2022). Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials. Diabetic Medicine, 39. https://doi.org/10.1111/dme.14780

Chicago

Ruth Sim, Chun Wie Chong, Navin K. Loganadan, Alan Y. Y. Fong, Leenhapong Navaravong, Zanariah Hussein, Kamlesh Khunti, and Shaun Wen Huey Lee. 2022. “Comparative Effectiveness of Cardiovascular, Renal and Safety Outcomes of Second‐line Antidiabetic Drugs Use in People with Type 2 Diabetes: A Systematic Review and Network Meta‐analysis of Randomised Controlled Trials.” Diabetic Medicine 39 (January). doi:10.1111/dme.14780.